Upregulation of P53 Gene Expression on Breast Cancer Stem Cells Treated with Trisindoline 5 Compound
International Journal of Cell and Biomedical Science · 2022
DOI: 10.59278/cbs.v1i2.20 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cell and Biomedical Science, 2022. Verfasst von Yofinta I Salsabila und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Cancer stem cells (CSCs) are the subpopulation of cancer cells that have been demonstrated as the cause of tumor formation. The most common cancer for women and the second leading cause of death in breast cancer. Numerous genes have been involved in breast cancers, including p53. In cancer cells, p53 as well-known as the tumor suppressor gene plays an important role in directing cells with DNA damage into apoptosis. Trisindolines are heterocyclic nitrogen compounds consisting of an isatin core bearing two indole moieties that provide cytotoxic effects on cancer cells. Recently research had led to the development of the new modification of trisindoline compound into trisindoline 5.
Objective
This study aims to investigate the effect of trisindoline 5 compounds against p53 gene expression in CSCs MDA-MB-231 in vitro.
Methods
CSCs MDA-MB-231 were divided into control and treatment groups which were further analyzed in gene expression using the qPCR Livak method.
Results
Based on gene expression analysis, trisindoline 5 increases the expression of p53 in CSCs MDA-MB-231.
Conclusion
This study informed that trisindoline 5 could upregulate the expression of tumor suppressor gene p53 in CSCs MDA-MB-231 in vitro.
Zitieren
APA
Salsabila, Y. I., Azhaar, N., Fatoni, M., Nurhayati, A. P., Ghaissani, S. S., Andifa, V. A. N., Santoso, M., & Martak, F. (2022). Upregulation of P53 Gene Expression on Breast Cancer Stem Cells Treated with Trisindoline 5 Compound. International Journal of Cell and Biomedical Science. https://doi.org/10.59278/cbs.v1i2.20
Vancouver
Salsabila YI, Azhaar N, Fatoni M, Nurhayati AP, Ghaissani SS, Andifa VAN, et al. Upregulation of P53 Gene Expression on Breast Cancer Stem Cells Treated with Trisindoline 5 Compound. International Journal of Cell and Biomedical Science. 2022. doi:10.59278/cbs.v1i2.20
BibTeX
@article{Salsabila2022,
author = {Salsabila, Yofinta I and Azhaar, Nadia and Fatoni, Muhammad and Nurhayati, Awik P.D. and Ghaissani, Shabrina Syifa and Andifa, Vinda Aprilia Nurul and Santoso, Mardi and Martak, Fahimah},
title = {Upregulation of P53 Gene Expression on Breast Cancer Stem Cells Treated with Trisindoline 5 Compound},
journal = {International Journal of Cell and Biomedical Science},
year = {2022},
doi = {10.59278/cbs.v1i2.20}
}
EUVIMED